S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
NASDAQ:TRNS

Transcat (TRNS) Stock Forecast, Price & News

$97.02
+1.96 (+2.06%)
(As of 05:19 PM ET)
Compare
Today's Range
$94.90
$97.02
50-Day Range
$83.58
$114.48
52-Week Range
$65.60
$115.41
Volume
66,913 shs
Average Volume
46,783 shs
Market Capitalization
$773.35 million
P/E Ratio
70.30
Dividend Yield
N/A
Price Target
$105.50

Transcat MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
8.7% Upside
$105.50 Price Target
Short Interest
Healthy
1.50% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.83mentions of Transcat in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$1.12 M Sold Last Quarter
Proj. Earnings Growth
16.87%
From $1.66 to $1.94 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.10 out of 5 stars

Computer And Technology Sector

219th out of 604 stocks

Instruments To Measure Electricity Industry

5th out of 8 stocks


TRNS stock logo

About Transcat (NASDAQ:TRNS) Stock

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.

TRNS Price History

TRNS Stock News Headlines

Why Transcat Shares Are Sliding Today
Transcat Shares Drop 10% After Public Offering Prices
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
3 Reasons Growth Investors Will Love Transcat, Inc. (TRNS)
Transcat: Performing Well But Currently Overvalued
Craig-Hallum Reaffirms Their Buy Rating on Transcat (TRNS)
H.C. Wainwright Remains a Buy on Transcat (TRNS)
Transcat (TRNS) Stock Exceeded Expectations in Q1
Transcat (TRNS) Gets a Buy from H.C. Wainwright
See More Headlines
Receive TRNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Transcat and its competitors with MarketBeat's FREE daily newsletter.

TRNS Company Calendar

Last Earnings
7/31/2023
Today
9/27/2023
Next Earnings (Estimated)
10/30/2023
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Instruments to measure electricity
Sub-Industry
N/A
Current Symbol
NASDAQ:TRNS
Employees
1,030
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$105.50
High Stock Price Forecast
$112.00
Low Stock Price Forecast
$94.00
Forecasted Upside/Downside
+9.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$10.69 million
Pretax Margin
5.84%

Debt

Sales & Book Value

Annual Sales
$230.57 million
Cash Flow
$2.90 per share
Book Value
$13.18 per share

Miscellaneous

Free Float
7,636,000
Market Cap
$766.95 million
Optionable
Not Optionable
Beta
0.67
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Lee D. RudowMr. Lee D. Rudow (Age 59)
    Pres, CEO & Director
    Comp: $816.46k
  • Mr. Thomas Barbato (Age 54)
    CFO & Treasurer
    Comp: $398.09k
  • Mr. Mark A. Doheny (Age 51)
    Chief Operating Officer
    Comp: $399.69k
  • Mr. James M. Jenkins J.D. (Age 59)
    Chief Legal Officer, Corp. Devel. Officer & Corp. Sec.
    Comp: $403.63k
  • Ms. Theresa A. Conroy (Age 59)
    Sr. VP of HR
    Comp: $294.66k
  • Mr. Scott D. DeverellMr. Scott D. Deverell (Age 57)
    Corp. Controller & Principal Accounting Officer
  • Ms. Marcy Bosley (Age 44)
    VP of Sales
  • Mr. Michael W. West (Age 52)
    Sr. VP of Bus. Operations













TRNS Stock - Frequently Asked Questions

Should I buy or sell Transcat stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TRNS shares.
View TRNS analyst ratings
or view top-rated stocks.

What is Transcat's stock price forecast for 2023?

4 brokers have issued 1 year price objectives for Transcat's shares. Their TRNS share price forecasts range from $94.00 to $112.00. On average, they predict the company's share price to reach $105.50 in the next twelve months. This suggests a possible upside of 9.6% from the stock's current price.
View analysts price targets for TRNS
or view top-rated stocks among Wall Street analysts.

How have TRNS shares performed in 2023?

Transcat's stock was trading at $70.87 at the beginning of 2023. Since then, TRNS shares have increased by 35.8% and is now trading at $96.23.
View the best growth stocks for 2023 here
.

When is Transcat's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our TRNS earnings forecast
.

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) posted its earnings results on Monday, July, 31st. The scientific and technical instruments company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.27 by $0.11. The scientific and technical instruments company had revenue of $60.60 million for the quarter, compared to the consensus estimate of $59.63 million. Transcat had a trailing twelve-month return on equity of 10.62% and a net margin of 4.47%.

What ETFs hold Transcat's stock?

ETFs with the largest weight of Transcat (NASDAQ:TRNS) stock in their portfolio include Invesco DWA SmallCap Momentum ETF (DWAS).AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC).

What is Lee Rudow's approval rating as Transcat's CEO?

20 employees have rated Transcat Chief Executive Officer Lee Rudow on Glassdoor.com. Lee Rudow has an approval rating of 69% among the company's employees.

What other stocks do shareholders of Transcat own?
What is Transcat's stock symbol?

Transcat trades on the NASDAQ under the ticker symbol "TRNS."

Who are Transcat's major shareholders?

Transcat's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (9.50%), BlackRock Inc. (6.44%), Champlain Investment Partners LLC (5.08%), Royce & Associates LP (4.27%), Dimensional Fund Advisors LP (2.59%) and Wasatch Advisors LP (2.49%). Insiders that own company stock include Carl E Sassano, Charles P Hadeed, Craig D Cairns, Gary J Haseley, Lee D Rudow, Lee D Rudow, Michael W West, Richard J Harrison and Scott Deverell.
View institutional ownership trends
.

How do I buy shares of Transcat?

Shares of TRNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Transcat's stock price today?

One share of TRNS stock can currently be purchased for approximately $96.23.

How much money does Transcat make?

Transcat (NASDAQ:TRNS) has a market capitalization of $766.95 million and generates $230.57 million in revenue each year. The scientific and technical instruments company earns $10.69 million in net income (profit) each year or $1.38 on an earnings per share basis.

How many employees does Transcat have?

The company employs 1,030 workers across the globe.

How can I contact Transcat?

Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The official website for the company is www.transcat.com. The scientific and technical instruments company can be reached via phone at (585) 352-7777, via email at mtschiderer@transcat.com, or via fax at 585-352-1486.

This page (NASDAQ:TRNS) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -